According to filings with the U.S. Securities and Exchange Commission, Scripta Insights is raising up to $16,749,982.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About Scripta Insights
The Pharmacy Benefits Savings Experts Scripta is a unique company dedicated to stopping out of control pharmacy benefit spending before it starts for self-insured employers. Our exclusive software analyzes all pharmacy transactions every month, compares them to your PBM contract, and to our exclusive Med Mapping Software. The result? A level of transparency and cost-control never before available to payers. Our clients see savings of up to 35% on their pharmacy benefit spend. Scripta your data, our platform, big savings! .

To learn more about Scripta Insights, visit http://www.scriptainsights.com/
Scripta Insights Linkedin Page: https://www.linkedin.com/company/scriptainsights/

Contact:
Eric Levin, Chief Executive Officer
866-572-7478
https://www.linkedin.com/in/eric-levin-048138/

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.